Eli Lilly and Company stock research
FY2024 Q4
Eli Lilly and (LLY) Gross Margin — Quarter Ended Dec 31, 2024
Revenue and gross profit both increased compared to the prior quarter and the same quarter last year. Gross margin improved as cost of revenue grew at a slower pace than revenue.
Gross margin takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue and gross profit both increased compared to the prior quarter and the same quarter last year. Gross margin improved as cost of revenue grew at a slower pace than revenue.
- The primary driver of the gross margin improvement was revenue growth exceeding the increase in cost of revenue.
- Compared to the immediately preceding quarter, gross margin was higher. Compared to the same quarter one year earlier, gross margin was also higher.
Gross margin snapshot
The selected quarter's reported revenue, gross profit, direct costs, and margin comparisons.
Gross margin
82.2%
Gross profit
$11.1B
Revenue
$13.5B
Cost of revenue
$2.4B
Quarter-over-quarter change
+1.2 pts
Year-over-year change
+1.4 pts
Quarterly gross margin trend
A four-quarter view of the revenue and direct-cost bridge behind gross margin.
| Period | Revenue | Gross profit | Cost of revenue | Gross margin |
|---|---|---|---|---|
| Mar 31, 2024 | $8.8B | $7.1B | $1.7B | 80.9% |
| Jun 30, 2024 | $11.3B | $9.1B | $2.2B | 80.8% |
| Sep 30, 2024 | $11.4B | $9.3B | $2.2B | 81.0% |
| Dec 31, 2024 | $13.5B | $11.1B | $2.4B | 82.2% |
Quarterly comparisons
Compare the selected margin with the preceding quarter and the same fiscal quarter one year earlier.
Previous-quarter change
Sep 30, 2024
+1.2 pts
Year-over-year change
Dec 31, 2023
+1.4 pts
What the margin says
Filing-constrained interpretation of margin direction, comparisons, and what to monitor next.
The primary driver of the gross margin improvement was revenue growth exceeding the increase in cost of revenue.
Compared to the immediately preceding quarter, gross margin was higher. Compared to the same quarter one year earlier, gross margin was also higher.
Monitor the impact of the company's ongoing investments in manufacturing capacity on future cost of revenue and gross margin.